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1. Introduction
Colorectal carcinoma ranks as the third most commonly diagnosed cancer and the second
leading cause of death from cancer in the United States [1]. It is estimated that more than
150,000 new cases are diagnosed with more than 50,000 dying from the disease yearly in
the U.S. alone [1]. Similar to other cancers, it is often diagnosed at advanced stage, after
the patient has developed symptoms. Many colon cancer deaths can be avoided because
mostly they arise from adenomatous polyps, which may be detectable years before malig‐
nant transformation.
Since the first report of a complete examination of the entire colon using a flexible endo‐
scope, optical colonoscopy (OC) has evolved to be the current gold standard for evaluation
of the colon [2]. OC has several limitations and drawbacks as a population-based screening
tool. It is an invasive procedure requiring sedation. An escort is usually required to take the
patient home, which increases the cost of the procedure from a societal perspective. OC also
carries a small but significant risk of perforation and death. The risk of colonic perforation is
about 1 per 1,000 cases and death is approximately 1 in 5,000 cases [3-5]. Failure to reach the
cecum (5-10%) and missed polyps (10-20%) also are known limitations of the current gold
standard test [6-9].
Computed tomographic colonography (CTC), also known as "virtual colonoscopy" was first
described more than a decade ago [10]. In the early 1990’s, several pilot studies evaluated
the feasibility of (CTC) [11]. The advantages of developing a computerized-based screening
tool includes: increased accessibility, non-invasiveness, and no sedation required [12]. These
advantages of CTC may help to increase compliance with current screening recommenda‐
tion guidelines [13].
© 2013 Richards and Liang; licensee InTech. This is an open access article distributed under the terms of the
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2. Technique
As advancements in scanner technology and three-dimensional (3D) post-processing helped
develop this method to mature into a potential option in screening for colorectal cancer, the
fundamentals of the examination remained the same. It is a minimally invasive, CT-based
procedure that simulates conventional colonoscopy using 2D and 3D computerized recon‐
structions [10]. CTC utilizes computer virtual-reality techniques to navigate inside a three-
dimensionalz (3D) patient-specific colon model reconstructed from abdominal CT images,
looking for polyps.
CTC examination starts by inflating a cleansed colon with room air or carbon dioxide (CO2)
introduced through rectal catheter [14]. With the patient in a prone position, air or CO2 is
insufflated under gentle pressure to ensure adequate distention of the bowel. The insuffla‐
tion of gas is usually associated with a mild degree of patient discomfort or pain [15]. Al‐
though not common, vaso-vagal reactions can occur, especially if with small bowel
distention occurs [16].
Then abdominal CT slice images are taken in seconds (during a single breath hold) with sub
millimeter resolution in both axial and transverse directions resulting in excellent contrast
between the colon wall and the lumen. The sliced images are stacked together as a volume
image, from which the colon model is constructed. Image segmentation is necessary for the
construction of an accurate colon model. Computer graphics are heavily involved to navi‐
gate or fly through inside the 3D colon model. The patient is scanned in both a prone and
supine view [17]. Using a second view significantly improves the ability to identify patients
with polyps 0.5 cm in diameter or larger [18].
CTC can be performed in patients with prior abdominoperineal resection and sigmoid co‐
lostomy,  although increased difficulties  with CO2 retention and adequate  bowel  disten‐
tion exist [19]. The prevalence of transient bacterium after CTC is low therefore it follows
that patients with at risk cardiac lesions should not require antibiotic prophylaxis before‐
hand [20].
Most commonly used bowel preparations include sodium phosphates, magnesium citrate
and polyethylene glycol (PEG) [21]. Typical oral preparations used for bowel cleansing are:
4 L of PEG solution; 90 ml of phosphosoda; or 300 ml of magnesium citrate. Polyp detection
is comparable for all three preparations, although phosphosoda has a significantly higher
patient compliance and the least residual stool [22]. Residual fluid coverage negatively af‐
fects the quality of CTC [23].
The use of fecal tagging agents and intravenous contrast is not standardized. CTC experts
were surveyed regarding their practice patterns [24]. Thirty-eight percent performed fecal
tagging regularly and 81% [21/26] believed intravenous contrast was not necessary [24].
Non-operator  dependent  false  positives  and false  negatives  occur  with  CTC.  For  exam‐
ple,  inadequately  tagged stool  can have the  same density  as  a  polyp,  however  the  two
can  sometimes  be  distinguished  by  comparing  prone  and  supine  views,  since  stool  is
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usually mobile and polyps are not.  The rectal balloon is a potential  blind spot for CTC,
sometimes masking significant lesions [25, 26]. Also, poor colonic distention can result in
a false negative reading [27].
3. Screening for colorectal cancer: CTC vs. OC
The primary aim of CTC is the detection of colorectal polyps and carcinomas, however; the
precise role of CTC in screening asymptomatic patients is controversial [28]. Studies using
patients with known adenomas generally report higher accuracy, while studies employing
asymptomatic screening subjects report lower accuracy [28]. Two key areas have held back
the widespread application of CTC as a screening test. These key areas are: [1] the variable
sensitivity of CTC reported in mass screening programs (see Table) and [2], the expertise re‐
quired to interpret the examination. These two areas are related [29]. Despite these draw‐
backs, the American College of Radiology, has endorsed the use of CTC as a screening tool
for colo-rectal cancer stating that the sensitivity and specificity of CTC are high enough and
comparable to those of OC [30]. In addition, CTC has received the endorsement of a multi-
society task force that included the American Cancer Society and U. S. Multi-society Task
Force on Colorectal Cancer [31].
Studies reveal a wide variation in performance measures (sensitivity and specificity) regard‐
ing polyp detection rates, especially for smaller polyps [10]. In an early feasibility study of
44 patients, CTC demonstrated reasonable sensitivity (83%) and specificity (100%) for pol‐
yps larger than 8 mm in size [32]. A second early study performed in 87 patients at high risk
for colorectal neoplasia identified 49 patients with a total of 115 polyps and 3 carcinomas
[33]. CTC identified all 3 cancers. The sensitivity was 91% for polyps that were 10 mm or
more in diameter, 82% [33/40] that were 6 to 9 mm, and 55% [29/53] that were 5 mm or
smaller [33]. There were 19 false positive findings of polyps and no false positive findings of
cancer. In a larger study of 300 patients CTC demonstrated a sensitivity equal to 90% for
polyps 10 mm or larger and 80.1% for polyps at least 5 mm in size [34]. The overall specifici‐
ty for this study was 72.0% [34]. All 8 carcinomas in the study were detected by CTC.
Two later studies assessing the accuracy of CTC had varying results. Pickhardt et al. evalu‐
ated 1,233 asymptomatic patients with CTC and same-day OC [35]. The sensitivity of CTC
for adenomatous polyps at least 10 mm in size was 93.8% and 88.7% for polyps at least 6
mm in size, which was comparable to OC. The specificity of CTC for adenomatous polyps at
least 10 mm in size was 96.0% and 79.6% for polyps at least 6 mm in size. These encouraging
results were followed a year later by less optimistic findings from a study by Cotton et al.,
that analyzed 600 participants undergoing both CTC and OC [36]. In the Cotton study, 104
of the participants (17.3%) had lesions sized at least 6 mm. The sensitivity of CTC for detect‐
ing 1 or more lesions sized at least 6 mm was only 39.0% and for lesions sized at least 10
mm, it was 55.0% (95% Cl, 39.9% - 70.0%) [36]. The specificity of CTC for detecting partici‐
pants without any lesion sized at least 6 mm was 90.5% and without lesions sized at least 10
mm, 96.0% (95% Cl, 94.3% - 97.6%). CTC missed 2 of 8 cancers [36]. Lack of adequate radiol‐
ogist training to read CTCs may have resulted in the low accuracy found in this study.
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In a subsequent study of 2,531 asymptomatic patients, radiologists trained in CTC reported
the accuracy of finding histologically confirmed adenomas [37]. The sensitivity for large ad‐
enomas [10 mm or larger) and medium-sized adenomas (6 – 9 mm) was 90% and 78% re‐
spectively [37]. CTC failed to detect a lesion measuring 10 mm or more in diameter in 10%
of patients [37]. Pickhart et al. found that the positive predictive values (PPV) for polyps
with threshold sizes 6 mm, 8 mm, and 10 mm are: 92.3%, 93.0%, and 93.1% respectively [38].
Others have also found that for significant adenomas, the PPV of CTC is high and ranges
from 96 – 99% [37, 39].
Meta-analysis is a tool that attempts to summarize varying results across multiple studies.
Meta-analysis of data suggests CTC has excellent per-patient average sensitivity and aver‐
age specificity for detection of adenomatous polyps and cancer [40]. In one meta-analysis,
2,610 patients were included for study [41]. Large polyps (10 mm or greater) had a per-pa‐
tient average sensitivity of 93% (95% CI,73% - 98%) and specificity of 97% 9(95% CI, 95% -
99%) [41]. The sensitivity and specificity decreased to 86% (95% CI: 75% - 93%) and 86%
(95% CI, 76% - 93%), respectively, when the threshold was lowered to include medium sized
polyps (6 mm to 9 mm). These findings are similar to another more recent meta-analysis us‐
ing average risk patients that found a sensitivity of 87% and specificity of 97.6% for polyps
at least 10 mm in size [42].
One of the problems of evaluating the test performance of CTC is the use of OC as the gold
standard because OC has a miss-rate for polyps and cancer as well. In one study, Pickhardt
et al. compared 1,233 asymptomatic adults who underwent same-day CTC and blinded seg‐
mental OC [43]. Polyps that were detected by CTC but initially missed by OC were consid‐
ered missed polyps for OC. It was found that OC had a miss rate of 12% for adenomas 10
mm or greater. Of the missed polyps on OC, 14/15 (93.3%) non-rectal neoplasms were locat‐
ed on a fold. Five of 6 (83.3%) missed rectal lesions were located within 10 cm of the anal
verge [43].
Another study analyzed 286 tandem colonoscopies [44]. The OC miss rates for adenomas 5
mm and larger and advanced adenomas (≥ 10 mm or high grade dysplasia) were: 11% and
9% respectively [44]. Therefore, OC does have a significant miss rate for adenomas 5 mm
and larger and/or advanced adenomas. In fact, the OC miss-rate is similar to the CTC miss-
rate for polyps 6-9 mm in size [27]. It should also be pointed out that in screening studies,
CTC and OC have similar detection rates for advanced neoplastic polyps and cancer, 3.2%
vs. 3.4% respectively [45]. OC detects significantly more adenomas less than 5 mm of size
although the benefit of this remains to be seen [46]. In summary, CTC appears to have simi‐
lar sensitivity to OC in detecting polyps 5 mm or greater when performed by readers with
high experience [47].
The detection of flat adenomas are a major concern for colo-rectal cancer screening since
these polyps are at a higher risk of harboring advanced pathology and are more difficult to
detect by CTC as well as OC [48, 49]. In the general population, there is wide variation in the
reported incidence of flat lesions, which may in part be due to the lack of a uniform defini‐
tion of flat polyps. Various definitions of flat polyps have been used in CTC studies. For ex‐
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ample, in one study flat polyps were defined as those having a height less than one-half of
their width [50]. In other studies, a definition of 3 mm or less in height is used [51].
The sensitivity for flat polyps appears to be lower than non-flat polyps, however, Pickhardt
et al. found that the sensitivity of CTC for detecting flat adenomas measuring 6 mm or
greater was similar to that of non-flat polypoid lesions [50]. Others have found lower sensi‐
tivities for flat polyps ranging from 15% to 65% [52]. Regardless of reader skills, truly flat or
depressed adenomas will most likely pose a challenge for CTC. Also, flat carpet lesions of
the colon can be difficult to detect by CTC [53].
CTC readers may not report polyps less than 5 mm in size [54]. The justification for this is
that small polyps are usually benign and rarely harbor cancer or have much prognostic sig‐
nificance. In a large OC screening study, advanced histology was found in only 1.7% of pol‐
yps sized 5 mm or less indicating the lack of reporting of these small polyps by CTC may be
justified [55]. On the other hand, 6.6% of polyps sized 6 to 9 mm, had an advanced histology
implying polyps of this size if found on CTC should be followed up with OC in the near
future [55]. This last point is somewhat contentious and some radiologic guidelines suggest
surveillance with CTC after a shortened interval as an acceptable option for polyps 6 – 9 mm
in size [56].
We feel a reasonable algorithm for CTC screening might be: 1. follow-up screening in 5
years if no polyps are found: 2. Follow-up CTC or OC in 5 years for polyps smaller than 5
mm: 3. OC if polyps measuring 6 mm or greater are found [57]. This algorithm is consistent
with clinical sentiment since 71% of primary care physicians and 86% of gastroenterologists
would send patients with polyps 5 mm in size or greater for a follow-up OC [58]. If this ap‐
proach were adopted, a referral rate for OC of about 8% - 14% would be expected in the gen‐
eral population [45, 59]. Using a 6 mm threshold however may be very costly. A decision-
analysis estimated that to prevent one colon cancer death would require over 9,000 OCs,
resulting in 10 additional perforations at an incremental cost of $327,853 dollars [60].
4. Other uses of CTC
4.1. After incomplete colonoscopy
Sometimes OC can not be completed to the cecum due to technical factors such as prior ab‐
dominal surgery, colon length and number of flexures [61]. An important use of CTC is ex‐
amination of the colon after incomplete OC [62]. In a retrospective study, 88/546 patients
had lesions 6 mm or greater on CTC after incomplete OC. OC was repeated if findings on
CTC were significant. The PPV of CTC for masses, large polyps, and medium polyps were
90.9% and 91.7%, and 64.7% respectively [63].
It may be valuable to perform a low-dose diagnostic CT before rectal tube insertion in pa‐
tients referred for incomplete colonoscopy. In one study of 262 patients referred for incom‐
plete OC, colon perforation was found on the low-dose CT scans of two of the 262 patients
(0.8%; 95% CI, 0.1-2.7%) [64]. One of these patients had no symptoms; the other had mild
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abdominal discomfort at the time of CTC. Therefore, the rate of occult colonic perforation
after incomplete colonoscopy may warrant a spot CT prior to full examination.
4.2. For symptoms
CTC is being increasingly used for the radiological evaluation of colorectal symptoms. In
symptomatic patients, CTC is equivalent to OC for diagnosing colon cancer and clinically
significant polyps [65]. In a retrospective study of 1,177 older symptomatic patients, 59 inva‐
sive CRC were detected [66]. Three small colorectal cancers were missed by CTC. CTC has a
high sensitivity (95%) and negative predictive value (99.7%) in excluding a CRC in patients
with colorectal symptoms [66].
4.3. Inflammatory bowel disease and diverticulitis
CTC may be useful for diagnosing and managing patients with inflammatory bowel disease
(IBD) [67]. CTC correctly identified acute and chronic IBD in 63.6%, and 100% of cases, re‐
spectively [68]. CTC was also helpful in assessing post-op strictures in Crohn’s disease pa‐
tients [69]. Perianastomotic narrowing or stenosis was detected by CTC in 11 of 15 patients.
The sensitivity and specificity for perianastomatic narrowing were 73% and 100% respec‐
tively [69]. The risk of perforation, especially in patients with severe active colitis is a poten‐
tial worry. Currently there is not enough data to measure the true risk in patients with
severe active disease [70].
Examination of the colon is usually necessary after an adequate rest period for evaluation of
patients with diverticulitis. CTC appears comparable to OC in the evaluation of these pa‐
tients and is a reasonable alternative in follow-up of patients with symptomatic diverticular
disease [71]. Diverticulosis may however, increase the chance of having a false positive test
for polyps on CTC due to the appearance of inverted diverticula and fecoliths[72]. On the
other hand, CTC may be helpful in diagnosing complications of diverticular disease and in‐
flammatory bowel disease, such as colo-vesicular fistulae [73].
4.4. Detection of tumor for surgery
CTC is very useful in detecting colon cancer after incomplete colonoscopy and also for eval‐
uating potential metastases [74-76]. CTC can help localize polyps or cancer prior to laparo‐
scopic surgery and detect synchronous lesions beyond the reach of OC due to obstructing
lesions [77, 78]. In fact, CTC is superior to OC in the localization of colonic tumors prior to
surgery [79]. CTC is also a safe and useful method for preoperative examination of the prox‐
imal colon after metallic stent placement in patients with acute colon obstruction caused by
cancer [80].
CTC is useful in surveillance after surgery for colo-rectal cancer, detecting local recurrence
and metastasis [81-84]. In patients with ovarian cancer CTC may be helpful in detecting rec‐
tosigmoid wall involvement wall and predict the need for rectosigmoid resection [85]. The
sensitivity, specificity, PPV and negative predictive value of CTC for the prediction of recto‐
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sigmoid resection in patients with ovarian cancer in one study were: 100%, 64.7%, 72.7% and
100%, respectively [85].
5. Reader experience and accuracy
Individual accuracy of reading polyps with CTC is highly variable among radiologists and
depends largely on training and experience [86-88]. There is a significant learning curve in‐
volved in the interpretation of CTC studies, with performance improving with operator ex‐
perience [89, 90]. Radiologists working in nonacademic centers may have less accurate
results than would be expected from published data originating from experienced academic
centers [91]. The steep learning curve involved with reading CTC has led some thought
leaders to advise against widespread colorectal cancer screening programs with CTC out‐
side of academic centers [29].
False negatives are a major concern, i.e. missing significant lesions. It appears that many
false negatives are due to observer error and not due to the technical capabilities of CTC. For
instance in one study, 53% of missed polyps (60 of 114) were attributed to observer-related
errors, and 26% were attributed to errors classified as technical [92]. This implies that with
improvements in reader skill the sensitivity of finding significant lesions would be accepta‐
ble and comparable to OC [90]. Technical factors that appear to be associated with higher
accuracy include meticulous bowel preparation and inflation, multidetector CT, combined
two and three-dimensional visualization [28, 93].
6. Radiation exposure
Radiation exposure at the time of CTC screening leads to a slight but increased risk of devel‐
oping cancer at a future time [94]. Therefore, reducing radiation exposure is a major chal‐
lenge for CTC screening.Currently, CTC scanning delivers a significant amount of X-ray
radiation exposure to the patient [95]. In 2004, a survey of 28 institutions revealed the me‐
dian effective dose of radiation was 5.1 mSv (range 1.2 mSv - 11.7 mSv) per position and the
median mAs value was 67 mAs[96].
Given current CT technology, a simple and effective strategy to reduce radiation would be
to lower the mAs level (i.e. deliver less X-ray photons to the body) during the data acquisi‐
tion. This strategy would however, lead to a higher noise signal in the acquired data. Recent
efforts on modeling a solution to avoid this noise artifact are aimed at minimizing the noise
prior or during image reconstruction. Despite the great effort on this solution in the past
decade, CTC still faces challenges at a mAs level lower than 50 [97].
A feasibility study examined low radiation doses from 10mAs to 40 mAs using adaptive
statistical iterative reconstruction (ASIR) models [98]. Eighteen patients were scanned with a
standard 50 mAs CTC dose in the supine position and a reduced dose of 25 mAs with 40%
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ASIR in the prone position. No significant image quality differences were seen between
standard-and low-dose images using 40% ASIR. The results of this pilot study show that the
radiation dose during CTC can be reduced 50% below currently accepted low-dose techni‐
ques without significantly affecting image quality when ASIR is used [98]. Larger studies
are needed to confirm this observation. Despite the increasing use of multi-slice scanners,
which are slightly less dose-efficient, the median effective dose remained approximately
constant between 1996 and 2004 [96]. Of 83 institutions, 62% used 64-detector row CT and 17
(50%) used dose modulation [99].
If the current CTC standards for radiation exposure are used for colorectal cancer screening,
CTC is still be a viable screening tool, even after taking into account the increased risks of
developing future cancers. Using a Monte Carlo simulation, it was found that for every 1
radiation-related cancer caused by CTC screening, 24 – 35 colorectal cancers would be pre‐
vented, implying a favorable risk to benefit ratio in favor of using CTC as a screening tool
[100]. This model assumed using CTC every 5 years in patients aged 50 – 80 years old and
using an estimated mean effective dose per CTC screening study of 8 mSv for women and 7
mSv for men.
An alternative solution to minimize the radiation is to use magnetic resonance imaging
(MRI) instead of CT for virtual colonoscopy, i.e., MR colonography (MRC) [101]. However,
this MRC alternative solution has several limitation compared to CTC. Currently it is more
costly, more sensitive to motion and other artifacts, and has lower spatial resolution but
with improvements with technology these disadvantages may be minimized.
7. Patient preferences
When asked if they would prefer CTC or OC, patients more often prefer CTC [102]. In one
study, 696 asymptomatic patients at high risk for colorectal cancer screening underwent
both CTC and OC [103]. Patients were asked using standardized forms about preparation
inconvenience and discomfort, examination discomfort and examination preference. Over‐
all, patients preferred CTC to OC (72.3% vs. 5.1%; P <0.001). Reported discomfort however,
was similar for CTC and OC (P = 0.63). In another study that evaluated patients with a histo‐
ry of diverticulitis, 74% preferred CTC preferred over OC [71]. Patients found colonoscopy
more uncomfortable (p < 0.03), more painful (p < 0.001), and more difficult (p < 0.01) than
CTC [71].
Other studies conflict with those mentioned above. Even though CTC is a less invasive alter‐
native than OC, procedural pain is not uncommon. In several studies, the pain associated
with CTC was higher than that associated with OC, albeit there is no sedation given for the
former test [104]. Using a time-trade off technique, 295 patients reported statistically more
pain and discomfort after CTC and showed preference for optical colonoscopy [105]. The
pain during CTC however, is usually not so severe as to abort the test [33].
In a well-designed study, 111 patients underwent CTC followed immediately by OC [15].
The preference  for  either  examination was evaluated after  completion of  both examina‐
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tions.  Of  the  68  patients  who  favored  one  examination,  56  [82%)  preferred  CTC  (P  <
0.00001). CTC was regarded as "not painful" by 62 (57%) of 108 patients compared with 28
(26%) for colonoscopy [15].
Intuitively we may believe that CTC, being a noninvasive test, would be preferred to OC
by most patients. However, when the risks of finding lesions that require follow-up and
other  factors  are  taken into  account,  patient  preferences  may change.  In  one study,  OC
was preferred over CTC as the need for a follow-up test  increased,  as the likelihood of
missing cancers or polyps increased, and as the cost for CTC increased (the odds rato of
preferring CTC to OC ranged from 0.65 to 0.80)[106]. Therefore, an informed decision re‐
garding CTC vs. OC should include a discussion of the benefits, risks, costs and associat‐
ed  uncertainties  of  the  tests.  In  summary,  patients  usually  prefer  CTC  to  OC  but  the
preference is most likely dependent on a number of other factors such as insurance cover‐
age, type of sedation used locally for OC, and the risk of finding a significant polyp on
CTC thereby requiring a follow-up OC.
8. Extracolonic findings
Extracolonic findings are an important issue for CTC as they increase costs and patient risk
by incurring addition tests. The frequency of extracolonic findings in the literature varies
considerably as there are no standards for their reporting nor what constitutes a clinically
significant extra-colonic finding. Some of the extracolonic lesions found are clinically impor‐
tant although most of them are incidental. In addition to increasing costs of CTC screening
programs, they may cause undue worry and anxiety for the patient.
The prevalence of extracolonic findings can be as high as 40% - 75% and are increased with
patient age [107-109]. Most extracolonic findings are incidental and not clinically important.
The most common extracolonic findings causing further evaluation in one study were lung
nodules and indeterminate kidney lesions adding a cost of $248 dollars per patient enrolled
for CTC screening [110].
In general, significant extracolonic findings are found in about 10 - 23% of patients undergo‐
ing CTC [111-113]. Potentially important extracolonic findings were seen in 15.4% (89 of 577)
of patients in one study, with a work-up rate of 7.8% (45 of 577)[114]. In another study only
4.4% - 6.0% of patients required follow-up radiologic testing for the extracolonic findings
[109]. Another study showed that 10% of 681 patients screened for colon cancer had extraco‐
lonic findings of high clinical importance [115].
Although extracolonic finding add cost to CTC screening programs, they may benefit pa‐
tients by diagnosing other potentially malignant lesions [112]. Unsuspected cancers (colonic
and extra-colonic) are found in about 0.5% of screening cases [116]. In a large study,
36/10,286 patients (0.35%) undergoing a screening examination had an unsuspected extraco‐
lonic cancer which included renal cell carcinoma (n = 11), lung cancer (n = 8), non-Hodgkin
lymphoma (n = 60, and a variety of other tumors (n = 11)[116). Other studies report a higher
rate of 2.7% of extracolonic cancer detection [107].
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9. Computer-Assisted Diagnosis (CAD)
An intensive area of research is the development of computer-assisted diagnosis (CAD) al‐
gorithms. CAD can assist radiologists as a second reader to improve accuracy [117, 118]. It
has been shown that CAD can aid trained radiologists in the detection of significant pol‐
yps [119].CAD significantly improved polyp detection by 12% in one study, (from 48 to
60%) with only a moderate increase in interpretation time [120].  Another study demon‐
strated that using CAD in second-read mode increased accuracy in 13 of 19 readers 968%);
CAD  increased  sensitivity  of  finding  polyps  but  decreased  specificity  slightly  [121].  In
general,  using  CAD increases  polyp  detection  but  also  increases  false  positives  as  well
[122, 123].
Using CAD as a primary reader is feasible but early studies showed less sensitivity than hu‐
man readers [124]. The sensitivity of CAD detected polyps 10 mm or greater was 64%
(18/28) in one study [125]. In a later study of 1,186 patients undergoing both CTC and OC on
the same day, CAD had a sensitivity of 89.3% (25/28; 95% CI: 71.8%-97.7%) for detecting ad‐
enomatous polyps at least 1 cm in size [126]. The false-positive rate was 2.1% (95% CI: 2.0% -
2.2%). CAD detected both of the carcinomas in the study group. In this study, CAD had a
per-patient sensitivity comparable to that of OC for adenomas at least 8 mm in size [126].
Another study found a per-patient sensitivity of 96% was for CAD (in patients with a me‐
dian polyp diameter of 6 mm) using external validation [127]. Several CAD polyp detection
systems exist such as Polyp Enhanced Viewing (PEV) and the Summers computer-aided de‐
tection (CAD) system (National Institutes of Health (NIH)). These systems vary and have
trade-offs in terms of sensitivity and specificity [128].
10. Safety
It is difficult to make a head-to-head comparison of the safety of CTC vs. OC since they are
different technologies with varying risks. In one study, CTC screening was performed in
3,120 adults and compared to primary OC screening in 3,163 adults. There were seven co‐
lonic perforations in the OC group and none in the CTC group [45]. Colonic perforation has
been reported with CTC but its occurrence is rare [129, 130]. Nine perforations out of 17,067
CTC examinations (0.052%) were reported in one study [131]. In another study of 11, 870
CTC studies, the perforation rate was 0.059% [132].
Possible factors that contribute to perforation are presence of an inguinal hernia contain‐
ing colon (n = 4), severe diverticulosis (n = 3), and obstructive carcinoma (n = 1)[132, 133].
In cases of obstructing lesions, gas should be insufflated slowly [133]. Colonic pneumato‐
sis  is  rarely  seen  (0.11%)  in  CTC studies  and  should  not  be  confused  with  perforation
[134,  135].  Overall,  potentially  serious adverse  events  related to  CTC occur  in  less  than
0.10% of patients [131].
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11. Cost-effectiveness
With a 6-mm size threshold for polyps, the overall referral rate to optical colonoscopy is
about 15% [114]. CTC is usually a less expensive test than OC, however the total costs may
not be less if one considers all of the variables such as compliance rates and referral rates for
OC after detecting lesions. Using a Markov model, screening by CTC costs $24,586 per life-
year saved compared to $20,930 for OC screening [136]. CTC becomes a more cost-effective
test as the compliance rate for screening increases or if the cost for CTC is 54% lower than
OC. On the other hand in a recent analysis both CTC and OC were more costly and less ef‐
fective than FOBT plus flexible sigmoidoscopy[137].
A Markov model was used to estimate the cost-effectiveness of CTC screening in an Italian
population. In this study, colorectal cancer was reduced by 40.9% and 38.2%, with OC and
CTC respectively. As compared to no screening, both CTC and OC were shown to be cost-
saving with CTC being the less expensive option [138]. Since CTC can accurately detect and
simultaneously screen for aortic aneurysms, cardiac atherosclerotic risk factors and osteopo‐
rosis, the benefits of CTC screening in an elderly population may be even more cost-effec‐
tive than previously thought [139-141].
12. New directions – Noncathartic bowel preparations
One new hope for the future is for patients to undergo CTC without laxatives or the need
for a purgative bowel preparation. Patients would only need to ingest fecal tagging agents
such as Gastroview or barium, one to two days before the test [142]. A pilot study using a
noncathartic bowel preparation (low fiber diet and fecal tagging) had disappointing results
demonstrating that the lack of bowel cleansing made the examination subjectively harder to
interpret and likely missed significant polyps [143]. A subsequent study however using a
noncathartic bowel preparation was performed in a high risk population [144]. Subjects in‐
gested 21.6 g of barium in nine divided doses. This study demonstrated that the sensitivity
of CTC using a non-cathartic bowel preparation for polyps greater than 9 mm was over 90%
[144].
Limited or non-cathartic bowel preparations may be especially useful in the frail or elderly
patient. In a prospective study, 67 elderly patients with reduced functional status under‐
went CTC using a limited bowel preparation consisting of a low-residue diet for 3 days, 1 L
of 2% oral diatrizoatemeglumine (Gastrografin) 24 hours before CTC, and 1 L of 2% oral
Gastrografin over the 2 hours immediately before CTC [145]. No cathartic preparation was
administered. All colonic segments were graded from 1 to 5 for image quality (1, unreada‐
ble; 2, poor; 3, equivocal; 4, good; 5, excellent). Overall image quality was rated good or ex‐
cellent in 84% of the colonic segments. Colonic abnormalities were identified in 12 patients
(18%), including four colonic tumors, two polyps, and seven colonic strictures [145].
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Ref. (%)Sensitivity (%)Sensitivity (%)Specificity (N) Patients
6 – 9 mm 1 cm or more
33 82 91 79 87
34 80 90 72 300
35 89 94 79 – 96 1,233
36 39 55 91 – 96 600
37 78 90 90 2,531
41* 86 93 97 2,610
42* 76 – 83 83 – 88 91 – 98 4,086
* Meta-analysis
Table 1. Sensitivity and specificity of polyps detected by CTC.
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